COVID-19患者静脉血栓栓塞症发生率:单中心大型学术医疗中心经验
该回顾性队列研究纳入2020年4月1日至27日在Temple大学医院住院的147例COVID-19患者,评估静脉血栓栓塞症(VTE)发生率及早期预测因素。
要点
- COVID-19住院患者中VTE发生率为17%,其中PE 16例、DVT 14例、两者兼有5例。
- 需有创机械通气(aOR 3.19,95%CI 1.07-9.55)与入院D-二聚体≥1500 ng/mL(aOR 3.55,95%CI 1.29-9.78)为VTE独立标志。
核心结论
- COVID-19住院患者中VTE发生率为17%,需有创机械通气及入院D-二聚体≥1500 ng/mL为VTE独立相关标志。
研究设计与样本
- 回顾性队列研究,纳入2020年4月1日至27日在Temple大学医院住院的147例COVID-19患者。
- 对临床高度怀疑急性VTE者行CT肺动脉造影和/或肢体静脉双功超声检查。
主要发现
- 147例中VTE总体发生率为17%(25/147),其中急性PE 16例、急性DVT 14例、PE合并DVT 5例。
- 需有创机械通气为VTE独立标志(aOR 3.19,95%CI 1.07-9.55)。
- 入院D-二聚体≥1500 ng/mL为VTE独立标志(aOR 3.55,95%CI 1.29-9.78)。
关键数值与推荐
- VTE诊断依据CT肺动脉造影和/或肢体静脉双功超声。
- 入院D-二聚体≥1500 ng/mL与VTE独立相关(aOR 3.55,95%CI 1.29-9.78)。
- 需有创机械通气与VTE独立相关(aOR 3.19,95%CI 1.07-9.55)。
临床怎么用
- 对临床高度怀疑VTE且存在有创机械通气或入院D-二聚体≥1500 ng/mL的COVID-19患者,应考虑早期VTE检测。
局限性
- 未对所有入院患者筛查VTE,真实发生率可能被低估。
- 研究结果为回顾性,需未来前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infection with the novel severe acute respiratory syndrome coronavirus 2 has been associated with a hypercoagulable state. Emerging data from China and Europe have consistently shown an increased incidence of venous thromboembolism (VTE). We aimed to identify the VTE incidence and early predictors of VTE at our high-volume tertiary care center. METHODS: We performed a retrospective cohort study of 147 patients who had been admitted to Temple University Hospital with coronavirus disease 2019 (COVID-19) from April 1, 2020 to April 27, 2020. We first identified the VTE (pulmonary embolism [PE] and deep vein thrombosis [DVT]) incidence in our cohort. The VTE and no-VTE groups were compared by univariable analysis for demographics, comorbidities, laboratory data, and treatment outcomes. Subsequently, multivariable logistic regression analysis was performed to identify the early predictors of VTE. RESULTS: The 147 patients (20.9% of all admissions) admitted to a designated COVID-19 unit at Temple University Hospital with a high clinical suspicion of acute VTE had undergone testing for VTE using computed tomography pulmonary angiography and/or extremity venous duplex ultrasonography. The overall incidence of VTE was 17% (25 of 147). Of the 25 patients, 16 had had acute PE, 14 had had acute DVT, and 5 had had both PE and DVT. The need for invasive mechanical ventilation (adjusted odds ratio, 3.19; 95% confidence interval, 1.07-9.55) and the admission D-dimer level ≥1500 ng/mL (adjusted odds ratio, 3.55; 95% confidence interval, 1.29-9.78) were independent markers associated with VTE. The all-cause mortality in the VTE group was greater than that in the non-VTE group (48% vs 22%; P = .007). CONCLUSIONS: Our study represents one of the earliest reported from the United States on the incidence rate of VTE in patients with COVID-19. Patients with a high clinical suspicion and the identified risk factors (invasive mechanical ventilation, admission D-dimer level ≥1500 ng/mL) should be considered for early VTE testing. We did not screen all patients admitted for VTE; therefore, the true incidence of VTE could have been underestimated. Our findings require confirmation in future prospective studies.
引用
- Rali P, O'Corragain O, Oresanya L, et al. Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic center. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32979557. doi:10.1016/j.jvsv.2020.09.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。